… Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular
outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without …

… trial, we show beneficial effects of dapagliflozin on kidney and … loss of kidney function as
reflected by the eGFR slopes over time. … developed kidney failure requiring dialysis or kidney …

… effects of dapagliflozin on the prespecified kidney and cardiovascular outcomes in
patients with chronic kidney disease … of cardiovascular disease, in the DAPA-CKD trial (Dapagliflozin …

… investigate the effects of dapagliflozin in chronic kidney disease (… kidney-specific composite
of sustained decline in eGFR of at least 50%, end-stage kidney disease, or death from kidney …

… with chronic kidney disease. We aimed to investigate the effects of dapagliflozin on kidney,
… according to underlying cause of chronic kidney disease, reported as diabetic nephropathy, …

… Thereby, our results show the effect of an SGLT2 inhibitor on both early … chronic kidney
disease in patients with type 2 diabetes. DECLARE–TIMI 58 is the first study to show the effects of …

… the effect of dapagliflozin by the underlying cause of chronic kidney disease, treatment with
dapagliflozin … than did placebo across different chronic kidney disease aetiologies (figure 2). …

… kidney effects of the SGLT2 inhibitor dapagliflozin in patients with proteinuric kidney disease
… on clinical kidney outcomes in patients with chronic kidney disease with and without …

… Whether this effect persists in patients with chronic kidney disease with and without type 2
… the effects of dapagliflozin on albuminuria in patients with chronic kidney disease with and …

… We characterized the effects of dapagliflozin 5 mg/day or dapagliflozin 10 mg/day versus
placebo on HbA1c, markers of kidney function [eGFR, urinary albumin:creatinine ratio (UACR), …